Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Frank Mott, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Florida, and Oklahoma. He is a Professor at Medical College of GA at GRU.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1991 - 1994- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1988 - 1991
Texas A&M; Health Science Center College of MedicineClass of 1988
Certifications & Licensure
FL State Medical License 2021 - Present
LA State Medical License 2011 - Present
TX State Medical License 1980 - 2025- TX State Medical License 1989 - 2025
OK State Medical License 2020 - 2021
GA State Medical License 2013 - 2017- LA State Medical License 2010 - 2017
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsFirst-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, Siqing Fu, Daniel D Karp
The Oncologist. 2024-04-04 - 1 citationsPerception of subjective lived experiences of individuals with anorexia-cachexia in patients with advanced lung cancer.Sriram Yennurajalingam, Frank Mott, Frank Mott, Zhanni Lu, Diana Urbauer
Asia-Pacific Journal of Oncology Nursing. 2023-11-01 - 3 citationsSafety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer.Mehmet Altan, Janet Tu, Denái R Milton, Bulent Yilmaz, Yanyan Tian
Cancer. 2023-09-01
Press Mentions
Nasopharyngeal Carcinoma Survivor: My Journey to Becoming an OncologistAugust 17th, 2020
Optimal Sequencing and Patient Selection Investigated in NSCLCDecember 4th, 2017
OncLive® to Host State of the Science Summit™ on Advanced Non-Small Cell Lung CancerOctober 25th, 2017
